KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for LifeMD (LFMD) over the last 10 years, with Q3 2025 value amounting to $269000.0.

  • LifeMD's Amortizatization of Intangibles rose 934.96% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 2552.76%. This contributed to the annual value of $8.0 million for FY2024, which is 4786.03% up from last year.
  • Latest data reveals that LifeMD reported Amortizatization of Intangibles of $269000.0 as of Q3 2025, which was up 934.96% from $261000.0 recorded in Q2 2025.
  • In the past 5 years, LifeMD's Amortizatization of Intangibles registered a high of $2.3 million during Q1 2025, and its lowest value of $617.0 during Q3 2021.
  • In the last 5 years, LifeMD's Amortizatization of Intangibles had a median value of $297500.0 in 2022 and averaged $711573.5.
  • Per our database at Business Quant, LifeMD's Amortizatization of Intangibles plummeted by 9926.46% in 2021 and then skyrocketed by 5273630.47% in 2022.
  • LifeMD's Amortizatization of Intangibles (Quarter) stood at $617.0 in 2021, then soared by 151424.8% to $934908.0 in 2022, then surged by 75.11% to $1.6 million in 2023, then soared by 30.49% to $2.1 million in 2024, then plummeted by 87.41% to $269000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $269000.0 for Q3 2025, versus $261000.0 for Q2 2025 and $2.3 million for Q1 2025.